Entrepreneur shares recession coping lessons
What I learned is that many baby boomer entrepreneurs have the same personal narrative.
Editorial: Unemployment cost increases on the way
California employers will soon experience one of those small but annoying prices we pay for doing business in the Golden State — higher costs for unemployment insurance.
Ford infusion a new model for banking
With a single brand, new systems, a seasoned team and a strong balance sheet, Pacific Capital Bancorp has gone from troubled bank to serious competitor.
Op/ed: Philanthropy is caught in a game of politics
In spite of the importance of addressing long-term fiscal imbalances, fooling with the philanthropic engine strikes me as short-sighted.
Editorial: Domestic violence is a business issue, too
We’ve been reminded recently of the tremendous toll that domestic violence takes on our region’s families and our economy and of the need for businesses to participate in dealing with this issue.
Amgen is Big Pharma’s newest player
Nov. 7, 2011 should be remembered as the date when Amgen resigned its charter membership in the biotech growth club and joined Big Pharma.
